State Street’s Serina Therapeutics SER Stock Holding History

State Street’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.8K	Hold	12,758	–	–	﹤0.01%	4121
2026 Q1	$24.8K	Hold	12,758	–	–	﹤0.01%	4203
2025 Q4	$24.4K	Hold	12,758	–	–	﹤0.01%	4229
2025 Q3	$68.4K	Buy	+12,758	New	+$67.9K	﹤0.01%	4109
2024 Q1	–	Sell	-762	Closed	-$10.3K	–	4409
2023 Q4	$10.3K	Hold	762	–	–	﹤0.01%	4395
2023 Q3	$18.2K	Hold	762	–	–	﹤0.01%	4454
2023 Q2	$23.9K	Hold	762	–	–	﹤0.01%	4573
2023 Q1	$17.8K	Hold	762	–	–	﹤0.01%	4697
2022 Q4	$14.8K	Hold	762	–	–	﹤0.01%	4770
2022 Q3	$15K	Hold	762	–	–	﹤0.01%	4861
2022 Q2	$15K	Sell	762 -2	-0.3%	-$54	﹤0.01%	4900
2022 Q1	$23K	Hold	764	–	–	﹤0.01%	4875
2021 Q4	$29K	Hold	764	–	–	﹤0.01%	4762
2021 Q3	$25K	Hold	764	–	–	﹤0.01%	4679
2021 Q2	$42K	Buy	+764	New	+$38.3K	﹤0.01%	4443
2020 Q2	–	Sell	-8,356	Closed	-$273K	–	3867
2020 Q1	$273K	Buy	8,356 +884	+12%	+$41.6K	﹤0.01%	3539
2019 Q4	$478K	Buy	7,472 +320	+4%	+$17.3K	﹤0.01%	3531
2019 Q3	$493K	Buy	7,152 +2,206	+45%	+$209K	﹤0.01%	3512
2019 Q2	$638K	Sell	4,946 -638	-11%	-$86.4K	﹤0.01%	3484
2019 Q1	$795K	Sell	5,584 -1,063	-16%	-$155K	﹤0.01%	3380
2018 Q4	$699K	Buy	+6,647	New	+$845K	﹤0.01%	3392

Other funds holding SER

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.69B AUM 20.79% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AWE

Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

State Street's SER Position: Q2 2026 in Review

State Street held its Serina Therapeutics (SER) position steady in Q2 2026 at 12,758 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4121.

State Street first reported a position in SER in Q4 2018 and has held it in 21 quarters since. The position peaked at $795K in Q1 2019. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

State Street held 12,758 shares of Serina Therapeutics worth $24.8K as of Q2 2026.
State Street left its Serina Therapeutics share count unchanged in Q2 2026.
Serina Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4121 holding.
State Street first reported a position in Serina Therapeutics in Q4 2018 and has held it in 21 quarters since.
State Street's Serina Therapeutics position peaked at $795K in Q1 2019.
27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.